EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study

Chisom Kanu iD, Kristina S Boye iD, Jiat Ling Poon iD, Iris Goetz iD, Suzanne Williamson iD, Jitong Lou iD, Mark L Hartman iD, Corby K Martin iD, Tamer Coskun iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.70097 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Chisom Kanu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Appetite, Immunoglobulin Fc Fragments. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To determine whether adults with type 2 diabetes (T2D) treated with retatrutide report greater changes in self‐reported appetite, dietary restraint, and disinhibition compared to placebo or dulaglutide and to examine associations with weight change. Materials and Methods These pre‐specified exploratory analyses examined changes from baseline in Appetite Visual Analogue Scale (VAS) and Eating Inventory (EI) scores after 24 and 36 weeks of once‐weekly treatment with placebo, dulaglutide 1.5 mg, or retatrutide 0.5, 4, 8, or 12 mg in 275 adults with T2D. Changes from baseline with retatrutide were compared to those with placebo and dulaglutide. Post‐hoc correlations between changes in body weight and Appetite VAS/EI scores were also examined.

Results

Compared with placebo, participants who received retatrutide ≥4 mg reported greater reductions from baseline in overall appetite, hunger, and prospective food consumption (l at Week 24 (all p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like PeptidesAppetiteImmunoglobulin Fc FragmentsRecombinant Fusion ProteinsHypoglycemic AgentsFeeding BehaviorHumansFemaleMaleMiddle AgedAgedAdultWeight LossDouble-Blind MethodFatty AcidsPeptides

Stichwörter der Autor:innen

Retatrutideappetitedietary restraintdisinhibitioneating attitudeseating behavioursphase 2type 2 diabetes

Substanzen

Glucagon-Like PeptidesdulaglutideImmunoglobulin Fc FragmentsRecombinant Fusion ProteinsHypoglycemic AgentsretatrutideFatty AcidsPeptides

Autor:innen und Institutionen

  • Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Greenwich HE&OR Ltd., London, UK.
  • Ingestive Behavior, Weight Management & Health Promotion Laboratory, Human Phenotyping Core, Nutrition Obesity Research Center, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Loui…

ORCID-Profile: Chisom Kanu, Kristina S Boye, Jiat Ling Poon, Iris Goetz, Suzanne Williamson, Jitong Lou, Mark L Hartman, Corby K Martin, Tamer Coskun

Förderung

  • Eli Lilly and Company

Zitieren

APA

Kanu, C., Boye, K. S., Poon, J. L., Goetz, I., Williamson, S., Lou, J., Hartman, M. L., Martin, C. K., & Coskun, T. (2025). Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70097

Vancouver

Kanu C, Boye KS, Poon JL, Goetz I, Williamson S, Lou J, et al. Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70097

BibTeX
@article{Kanu2025,
  author = {Kanu, Chisom and Boye, Kristina S and Poon, Jiat Ling and Goetz, Iris and Williamson, Suzanne and Lou, Jitong and Hartman, Mark L and Martin, Corby K and Coskun, Tamer},
  title = {Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.70097}
}
Kostenlos starten →